ISCT Industry Membership Benefits
Access a global network of Key Opinion Leaders in cell and gene therapy translation
ISCT provides a unique collaborative environment, structured into three pillars of clinical translation:
Increase visibility for your company amongst leading organizations
The ISCT Commercialization Committee consists of a mix of leading therapeutic developers, CDMOs, tools, service, and product providers, plus academic thought leaders with the mandate of identifying and challenging the roadblocks to cell and gene therapy commercialization.
Contribute to consensus-building educational resources
The three Commercialization Sub-Committees develop subject-matter focused publications, webinars and reports to set industry standards on critical topics relevant to the development and delivery of cell and gene therapies.
*Participation within the Commercialization Committee and/or Sub-Committees is contingent on an Industry Community Membership with ISCT as outlined below.
Extend ISCT member benefits to your R&D and process development teams
Industry members have access to a complimentary laboratory membership which includes ISCT membership accounts for technical staff members working "at the bench", contributing to the clinical translation of cell and gene therapies.